Microfilament and microtubule function in human monocytes.

J J Rinehart; T Boulware

Home/Archive/PubMed

PubMed · 561822

Microfilament and microtubule function in human monocytes.

J J Rinehart·T Boulware

View original source ↗Export metadata ↓

Abstract

The functions of microfilaments and microtubules in human monocytes were examined by exposing peripheral blood monocytes to cytochalasin B, a microfilament inhibitor, and to colchicine, an antitubulin. Cytochalasin B, 10 microgram/ml, inhibited all monocyte functions tested: chemotaxis was reduced by 96% of control levels (p less than 0.01), random mobility by 88% (p less than 0.01), candidacidal activity by 57% (p less than 0.01), and phagocytosis by 34% (p less than 0.01). Monocyte adherence was also significantly reduced (by 65%). Colchicine, 10 microgram/ml, significantly reduced monocyte chemotaxis by 39% (p less than 0.01) and random mobility by 59% (p less than 0.01), but phagocytosis and candidacidal activity were not diminished at 0.1 to 100 microgram/ml. Monocyte adherence was modestly decreased (46%) by 10 microgram/ml of colchicine. Thus, cytochalasin B, a microfilament inhibitor, reduced all five functions tested. In contrast, colchicine, an antitubulin, inhibited only chemotaxis, random mobility, and adherence. These data suggest that in monocytes (1) microfilaments are the structural element of cell membrane and cytoplasm required for most cellular functions and (2) microtubules facilitate membrane surface interaction in chemotaxis, random mobility, and adherence.

Explore related subjects

Cell Adhesion Chemotaxis, Leukocyte Colchicine Cytochalasin B Cytoplasm Cytoskeleton Dose-Response Relationship, Drug Humans Microtubules Monocytes Phagocytosis Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

J J Rinehart, T Boulware. 1977. Microfilament and microtubule function in human monocytes.. https://pubmed.ncbi.nlm.nih.gov/561822/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Nanotopographical stimulation of mechanotransduction and changes in interphase centromere positioning.

We apply a recently developed method for controlling the spreading of cultured cells using electron beam lithography (EBL) to create polymethylmethacrylate (PMMA) substrata with repeating nanostructures. There are indications that the reduced cell spreading on these substrata, compared with planar PMMA, results from a reduced adhesivity since there are fewer adhesive structures and fewer of their associated stress fibres. The reduced cell spreading also results in a reduced nuclear area and a closer spacing of centrosomes within the nucleus, suggesting that the tension applied to the nucleus is reduced as would be expected from the reduction in stress fibres. In order to obtain further evidence for this, we have used specific inhibitors of components of the cytoskeleton and have found effects comparable with those induced by the new substrata. We have also obtained evidence that these subtrata result in downregulation of gene expression which suggests that this may be due to the changed tension on the nucleus: an intriguing possibility that merits further investigation.

Cell Adhesion↗

PubMed2007

BIG1, a brefeldin A-inhibited guanine nucleotide-exchange protein, is required for correct glycosylation and function of integrin beta1.

Glycosylation of beta1 integrin (beta1) in the Golgi complex has been related to its function in multiple cell processes, e.g., invasiveness, matrix adhesion, and migration. Brefeldin A-inhibited guanine nucleotide-exchange proteins (BIG) 1 and BIG2 activate human ADP-ribosylation factors (ARF) 1 and ARF3 by catalyzing the replacement of ARF-bound GDP with GTP to regulate Golgi vesicular transport. We show here a requirement for BIG1 (but not BIG2) in glycosylation and function of beta1. In HepG2 cells treated for 48 or 72 h with BIG1, but not BIG2, siRNA, both the amount and electrophoretic mobility of the initially 130-kDa beta1 were increased. BIG1 content had risen by 48 h after removal of BIG1 siRNA, and the faster-migrating, aberrant 130-kDa beta1 was not seen. Peptide N-glycosidase F, but not endoglycosidase H, digestion converted all beta1 to an approximately 85-kDa (core protein) form. By electron microscopy, Golgi membranes in BIG1-depleted cells were less sharply defined than those in mock or BIG2 siRNA-treated cells, with more vesicle-like structures at the transface. Amounts of active RhoA-GTP also were decreased in such cells and restored by overexpression of HA-BIG1. Aberrant beta1 was present on the cell surface, but its function in cell spreading, adhesion, and migration was impaired. By immunofluorescence microscopy, BIG1 siRNA-treated cells showed less spreading and concentration of beta1 at the cell surface. These results indicate a previously unrecognized role for BIG1 in the glycosylation of beta1 by Golgi enzymes, which is critical for its function in developmental and other vital cell processes.

Cell Adhesion↗

PubMed2007

Signaling requirements for translocation of P-Rex1, a key Rac2 exchange factor involved in chemoattractant-stimulated human neutrophil function.

PI 3,4,5-trisphosphate [PI(3,4,5)P3; PIP3]-dependent Rac exchanger 1 (P-Rex1) is a Rac-specific guanine nucleotide exchange factor abundant in neutrophils and myeloid cells. As a selective catalyst for Rac2 activation, P-Rex1 serves as an important regulator of human neutrophil NADPH oxidase activity and chemotaxis in response to a variety of extracellular stimuli. The exchange activity of P-Rex1 is synergistically activated by the binding of PIP3 and betagamma subunits of heterotrimeric G proteins in vitro, suggesting that the association of P-Rex1 with membranes is a prerequisite for cellular activation. However, the spatial regulation of endogenous P-Rex1 has not been well defined, particularly in human neutrophils activated through G protein-coupled receptors. Upon stimulation of neutrophil chemoattractant receptors, we observed that P-Rex1 translocated from cytoplasm to the leading edge of polarized cells in a G protein betagamma subunit- and PIP3-dependent manner, where it colocalized with F-actin and its substrate, Rac2. Redistribution of P-Rex1 to the leading edge was also dependent on tyrosine kinase activity and was modulated by cell adhesion. Furthermore, we observed that activation of cAMP-dependent protein kinase A (PKA), which phosphorylates and inactivates P-Rex1, inhibited its translocation. Our data indicate that endogenous P-Rex1 translocates to areas of Rac2 and cytoskeletal activation at the leading edge in response to chemoattractant stimuli in human neutrophils and that this translocation can be negatively modulated by activation of PKA and by cell adhesion.

Cell Adhesion↗